Potassium-competitive Acid Blocker-based Therapy for Helicobacter pylori Eradication
Article: Vonoprazan, a Novel Potassium-competitive Acid Blocker, as a Component of First-line and Second-line Triple Therapy for Helicobacter pylori Eradication: A Phase III, Randomised, Double-blind Study
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Jin Publishing & Printing Co.
2017-04-01
|
| Series: | The Korean Journal of Gastroenterology |
| Online Access: | http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2017.69.4.263 |